Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Antibe Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Licensing Agreements 12
Kwang Dong Pharma Enters into Licensing Agreement with Antibe Therapeutics 12
Laboratories Acbel Enters into Licensing Agreement with Antibe Therapeutics for ATB-346 13
Knight Therapeutics Enters into Licensing Agreement with Antibe Therapeutics 14
Equity Offering 15
Antibe Therapeutics Raises USD2.38 Million in Private Placement of Common Shares 15
Antibe Therapeutics Raises USD0.7 Million in Second Tranche Public Offering of Units 16
Antibe Therapeutics Raises USD3 Million in Public Offering of Units 18
Antibe Therapeutics Raises USD2 Million in Private Placement of Units 20
Antibe Therapeutics Raises USD0.4 Million in Second and Final Tranche of Private Placement of Units 21
Antibe Therapeutics Raises USD0.8 Million in First Tranche of Private Placement of Units 22
Antibe Therapeutics Raises USD0.5 Million in Private Placement of Units 24
Antibe Therapeutics Completes Second Tranche Of Private Placement Of Shares For US$3.5 Million 25
Antibe Therapeutics Completes Second Tranche Of Private Placement Of Units For US$1.2 Million 26
Antibe Therapeutics Completes IPO For US$3 Million 27
Antibe Therapeutics Completes Private Placement Of Common Stock For US$0.2 Million 29
Debt Offering 30
Antibe Therapeutics Raises USD0.3 Million in First Tranche of Private Placement of 10% Debentures Due 2018 30
Antibe Therapeutics Raises USD1.4 Million in First Tranche of Private Placement of 10% Debentures 31
Antibe Therapeutics Inc – Key Competitors 32
Antibe Therapeutics Inc – Key Employees 33
Antibe Therapeutics Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Jun 29, 2018: Antibe Therapeutics Reports 2018 Year-End Financial and Operating Results 35
Nov 28, 2017: Antibe Therapeutics Reports Q2 2018 Interim Financial and Operating Results and Provides Corporate Update 36
Aug 29, 2017: Antibe Therapeutics Reports Q1 2018 Interim Financial and Operating Results 37
Mar 01, 2017: Antibe Therapeutics Reports Q3 2017 Interim Financial and Operating Results 38
Corporate Communications 39
Oct 22, 2018: Antibe Therapeutics establishes business development Advisory Board 39
Product News 40
May 24, 2018: Calgary Researchers Discover a Novel Approach to Treatment of Inflammatory Bowel Diseases (IBD) Using Hydrogen Sulfide Technology 40
Clinical Trials 41
Apr 26, 2017: Antibe Therapeutics Advances Development of ATB-352 in Wake of Growing Global Opioid Epidemic 41
Other Significant Developments 42
Apr 03, 2018: Antibe Therapeutics Provides Financial Update 42
Appendix 43
Methodology 43
About GlobalData 43
Contact Us 43
Disclaimer 43
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Antibe Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Antibe Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Kwang Dong Pharma Enters into Licensing Agreement with Antibe Therapeutics 12
Laboratories Acbel Enters into Licensing Agreement with Antibe Therapeutics for ATB-346 13
Knight Therapeutics Enters into Licensing Agreement with Antibe Therapeutics 14
Antibe Therapeutics Raises USD2.38 Million in Private Placement of Common Shares 15
Antibe Therapeutics Raises USD0.7 Million in Second Tranche Public Offering of Units 16
Antibe Therapeutics Raises USD3 Million in Public Offering of Units 18
Antibe Therapeutics Raises USD2 Million in Private Placement of Units 20
Antibe Therapeutics Raises USD0.4 Million in Second and Final Tranche of Private Placement of Units 21
Antibe Therapeutics Raises USD0.8 Million in First Tranche of Private Placement of Units 22
Antibe Therapeutics Raises USD0.5 Million in Private Placement of Units 24
Antibe Therapeutics Completes Second Tranche Of Private Placement Of Shares For US$3.5 Million 25
Antibe Therapeutics Completes Second Tranche Of Private Placement Of Units For US$1.2 Million 26
Antibe Therapeutics Completes IPO For US$3 Million 27
Antibe Therapeutics Completes Private Placement Of Common Stock For US$0.2 Million 29
Antibe Therapeutics Raises USD0.3 Million in First Tranche of Private Placement of 10% Debentures Due 2018 30
Antibe Therapeutics Raises USD1.4 Million in First Tranche of Private Placement of 10% Debentures 31
Antibe Therapeutics Inc, Key Competitors 32
Antibe Therapeutics Inc, Key Employees 33
Antibe Therapeutics Inc, Subsidiaries 34
List of Figures
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Antibe Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Antibe Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10